Physician profile
Steven Milman
NPI 1588821078
$7,378.01
in general payments reported to CMS, 2019-2025
16 companies · $433 in 2025
The $433 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,264 · 2020: $2,621 · 2022: $94.71 · 2023: $23.79 · 2024: $941 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $841 · Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $841.20 |
| Food and Beverage | $556.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,501.52 | 2019-2024 | |
| Ethicon INC. | $168.94 | 2019 | |
| Merck Sharp & Dohme LLC | $96.20 | 2024-2025 | Keytruda, Keytruda Qlex |
| Philips North America LLC | $94.71 | 2022 | |
| Novartis Pharmaceuticals Corporation | $58.12 | 2025 | |
| Covidien LP | $56.03 | 2020 | |
| Mirati Therapeutics, INC. | $53.75 | 2023-2024 | Krazati |
| Janssen Biotech, INC. | $48.87 | 2025 | Erleada, Rybrevant |
| Agios Pharmaceuticals, INC. | $48.70 | 2025 | Pyrukynd |
| Eisai INC. | $44.43 | 2025 | |
| Celgene Corporation | $43.55 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $39.69 | 2025 | Lynparza |
| Genzyme Corporation | $38.58 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.32 | 2025 | Fruzaqla |
| Adc Therapeutics America, INC. | $28.40 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legend Biotech USA INC. | $23.20 | 2025 | Carvykti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Milman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.